Biologics slightly increase risk of skin cancer; TNF-blockers don't increase risk of other cancers

Source :: Health News Magazine. Dec, 2007, Vol. 13 Issue 12, p9, 1 p.
Publication Year :: 2007
Abstract: Use of biologic drugs known as tumor necrosis factor-alpha blockers including Enbrel (etanercept), Remicade (infliximab) and Humira (adalimumab) have revolutionized the treatment of rheumatoid arthritis (RA). But these drugs do [...]

Subjects :: Rheumatoid arthritis -- Care and treatment
Rheumatoid arthritis -- Risk factors
Rheumatoid arthritis -- Health aspects
Skin cancer -- Care and treatment
Skin cancer -- Risk factors
Skin cancer -- Health aspects
Antirheumatic agents -- Health aspects
Oncology, Experimental -- Health aspects
Cancer -- Care and treatment
Cancer -- Health aspects
Cancer -- Research
Health

Tools